publicaciones en revistas nacionales e internacionales · g, tabares-seisdedos r, ayuso-mateos jl,...

15
UNIDAD DE INVESTIGACIÓN EN PSIQUIATRÍA DE CANTABRIA | Hospital Universitario "Marqués de Valdecilla" | Servicio de Psiquiatría Residencia Cantabria, planta 12.ª Este | Avda. Cardenal Herrera Oria, s/n. | 39011 SANTANDER, C antabria, Spain Tel.: (+34) 942-202545 | Fax: (+34) 942-203447 | e-mail: [email protected] PUBLICACIONES EN REVISTAS NACIONALES E INTERNACIONALES Página 1 de 15 PUBLICACIONES EN REVISTAS NACIONALES E INTERNACIONALES 2013-2009 1. ALEMÁN-GÓMEZ Y, JANSSEN J, SCHNACK H, BALABAN E, PINA-CAMACHO L, ALFARO-ALMAGRO F, CASTRO-FORNIELES J, OTERO S, BAEZA I, MORENO D, BARGALLÓ N, PARELLADA M, ARANGO C, DESCO M. The Human Cerebral Cortex Flattens Turing Adolescence. J Neurosci. 2013 Sep 18;33(38):15004-15010. IF: 6,908 / D1 2. AYESA-ARRIOLA R, RODRÍGUEZ-SÁNCHEZ JM, PÉREZ-IGLESIAS R, ROIZ-SANTIÁÑEZ R, MARTÍNEZ-GARCÍA O, SÁNCHEZ-MORENO J, TABARÉS-SEISDEDOS R, VÁZQUEZ- BARQUERO JL, CRESPO-FACORRO B. Long-term (3-year) neurocognitive effectiveness of antipsychotic medications in first-episode non-affective psychosis: a randomized comparison of haloperidol, olanzapine, and risperidone. Psychopharmacology (Berl). 2013 Jun;227(4):615-25. IF: 4,061 / Q1 3. AYESA-ARRIOLA R, MANUEL RODRÍGUEZ-SÁNCHEZ J, PÉREZ-IGLESIAS R, GONZÁLEZ-BLANCH C, PARDO-GARCÍA G, TABARES-SEISDEDOS R, VÁZQUEZ- BARQUERO JL, CRESPO-FACORRO B. The relevance of cognitive, clinical and premorbid variables in predicting functional outcome for individuals with first- episode psychosis: A 3 year longitudinal study. Psychiatry Res. 2013 Oct 30;209(3):302-8. IF: 2,456 / Q2 4. AYESA-ARRIOLA R, PÉREZ-IGLESIAS R, RODRÍGUEZ-SÁNCHEZ JM, PARDO-GARCÍA G, TABARES-SEISDEDOS R, AYUSO-MATEOS JL, VÁZQUEZ-BARQUERO JL, CRESPO- FACORRO B. Predictors of neurocognitive impairment at 3-years after a first episode non-affective psychosis. Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jun 3;43:23-8. IF: 3,552 / Q1 5. AYESA-ARRIOLA R, ROIZ-SANTIAÑEZ R, PÉREZ-IGLESIAS R, FERRO A, SAINZ J, CRESPO-FACORRO B. Neuroanatomical differences between first-episode psychosis patients with and without neurocognitive deficit: a 3 year longitudinal study. Front Psychiatry. 2013 Oct 17;4:134. IF: - / - 6. BOBES J, IGLESIAS GARCÍA C, GARCÍA-PORTILLA GONZÁLEZ MP, BASCARÁN MT, JIMÉNEZ TREVIÑO L, PELAYO-TERÁN JM, RODRÍGUEZ REVUELTA J, SÁNCHEZ LASHERAS F, SÁIZ MARTÍNEZ P. Changes in administrative prevalence of mental disorders over a 13-year period in Asturias (northern Spain). Rev Psiquiatr Salud Ment. 2013 April - June;6(2):60-66. English, Spanish. IF: 0,667 / Q4 7. BOMBIN I, MAYORAL M, CASTRO-FORNIELES J, GONZALEZ-PINTO A, DE LA SERNA E, RAPADO-CASTRO M, BARBEITO S, PARELLADA M, BAEZA I, GRAELL M, PAYÁ B, ARANGO C. Neuropsychological evidence for abnormal neurodevelopment associated with early-onset psychoses. Psychol Med. 2013 Apr;43(4):757-68. IF: 5,587 / Q1 8. CARRAL-FERNÁNDEZ L, SEPULVEDA AR, GÓMEZ DEL BARRIO A, GRAELL M, TREASURE J. The Spanish validation of an Eating Disorders Symptom Impact Scale

Upload: others

Post on 26-Oct-2019

4 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: PUBLICACIONES EN REVISTAS NACIONALES E INTERNACIONALES · g, tabares-seisdedos r, ayuso-mateos jl, vÁzquez-barquero jl, crespo- FACORRO B. Predictors of neurocognitive impairment

UN

IDAD

DE

INVE

STIG

ACIÓ

N E

N P

SIQ

UIA

TRÍA

DE

CAN

TABR

IA |

Hos

pita

l Uni

vers

itario

"M

arqu

és d

e Va

ldec

illa"

| Se

rvic

io d

e Ps

iqui

atría

Resi

denc

ia C

anta

bria

, pla

nta

12.ª

Este

| Av

da. C

arde

nal H

erre

ra O

ria, s

/n.

| 390

11 S

ANTA

ND

ER, C

anta

bria

, Spa

in

Tel.:

(+34

) 942

-202

545

| Fax

: (+3

4) 9

42-2

0344

7 | e

-mai

l: ui

pcs1

1@hu

mv.

es

PUBLICACIONES EN REVISTAS NACIONALES E INTERNACIONALES

Página 1 de 15

PUBLICACIONES EN REVISTAS NACIONALES E INTERNACIONALES 2013-2009

1. ALEMÁN-GÓMEZ Y, JANSSEN J, SCHNACK H, BALABAN E, PINA-CAMACHO L, ALFARO-ALMAGRO F, CASTRO-FORNIELES J, OTERO S, BAEZA I, MORENO D, BARGALLÓ N, PARELLADA M, ARANGO C, DESCO M. The Human Cerebral Cortex Flattens Turing Adolescence. J Neurosci. 2013 Sep 18;33(38):15004-15010. IF: 6,908 / D1

2. AYESA-ARRIOLA R, RODRÍGUEZ-SÁNCHEZ JM, PÉREZ-IGLESIAS R, ROIZ-SANTIÁÑEZ R, MARTÍNEZ-GARCÍA O, SÁNCHEZ-MORENO J, TABARÉS-SEISDEDOS R, VÁZQUEZ-BARQUERO JL, CRESPO-FACORRO B. Long-term (3-year) neurocognitive effectiveness of antipsychotic medications in first-episode non-affective psychosis: a randomized comparison of haloperidol, olanzapine, and risperidone. Psychopharmacology (Berl). 2013 Jun;227(4):615-25. IF: 4,061 / Q1

3. AYESA-ARRIOLA R, MANUEL RODRÍGUEZ-SÁNCHEZ J, PÉREZ-IGLESIAS R, GONZÁLEZ-BLANCH C, PARDO-GARCÍA G, TABARES-SEISDEDOS R, VÁZQUEZ-BARQUERO JL, CRESPO-FACORRO B. The relevance of cognitive, clinical and premorbid variables in predicting functional outcome for individuals with first-episode psychosis: A 3 year longitudinal study. Psychiatry Res. 2013 Oct 30;209(3):302-8. IF: 2,456 / Q2

4. AYESA-ARRIOLA R, PÉREZ-IGLESIAS R, RODRÍGUEZ-SÁNCHEZ JM, PARDO-GARCÍA G, TABARES-SEISDEDOS R, AYUSO-MATEOS JL, VÁZQUEZ-BARQUERO JL, CRESPO-FACORRO B. Predictors of neurocognitive impairment at 3-years after a first episode non-affective psychosis. Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jun 3;43:23-8. IF: 3,552 / Q1

5. AYESA-ARRIOLA R, ROIZ-SANTIAÑEZ R, PÉREZ-IGLESIAS R, FERRO A, SAINZ J, CRESPO-FACORRO B. Neuroanatomical differences between first-episode psychosis patients with and without neurocognitive deficit: a 3 year longitudinal study. Front Psychiatry. 2013 Oct 17;4:134. IF: - / -

6. BOBES J, IGLESIAS GARCÍA C, GARCÍA-PORTILLA GONZÁLEZ MP, BASCARÁN MT, JIMÉNEZ TREVIÑO L, PELAYO-TERÁN JM, RODRÍGUEZ REVUELTA J, SÁNCHEZ LASHERAS F, SÁIZ MARTÍNEZ P. Changes in administrative prevalence of mental disorders over a 13-year period in Asturias (northern Spain). Rev Psiquiatr Salud Ment. 2013 April - June;6(2):60-66. English, Spanish. IF: 0,667 / Q4

7. BOMBIN I, MAYORAL M, CASTRO-FORNIELES J, GONZALEZ-PINTO A, DE LA SERNA E, RAPADO-CASTRO M, BARBEITO S, PARELLADA M, BAEZA I, GRAELL M, PAYÁ B, ARANGO C. Neuropsychological evidence for abnormal neurodevelopment associated with early-onset psychoses. Psychol Med. 2013 Apr;43(4):757-68. IF: 5,587 / Q1

8. CARRAL-FERNÁNDEZ L, SEPULVEDA AR, GÓMEZ DEL BARRIO A, GRAELL M, TREASURE J. The Spanish validation of an Eating Disorders Symptom Impact Scale

Page 2: PUBLICACIONES EN REVISTAS NACIONALES E INTERNACIONALES · g, tabares-seisdedos r, ayuso-mateos jl, vÁzquez-barquero jl, crespo- FACORRO B. Predictors of neurocognitive impairment

UN

IDAD

DE

INVE

STIG

ACIÓ

N E

N P

SIQ

UIA

TRÍA

DE

CAN

TABR

IA |

Hos

pita

l Uni

vers

itario

"M

arqu

és d

e Va

ldec

illa"

| Se

rvic

io d

e Ps

iqui

atría

Resi

denc

ia C

anta

bria

, pla

nta

12.ª

Este

| Av

da. C

arde

nal H

erre

ra O

ria, s

/n.

| 390

11 S

ANTA

ND

ER, C

anta

bria

, Spa

in

Tel.:

(+34

) 942

-202

545

| Fax

: (+3

4) 9

42-2

0344

7 | e

-mai

l: ui

pcs1

1@hu

mv.

es

PUBLICACIONES EN REVISTAS NACIONALES E INTERNACIONALES

Página 2 de 15

(EDSIS) among caregivers. Psychiatry Res. 2013 Oct 30;209(3):626-31. IF: 2,456 / Q2

9. CRESPO-FACORRO B, PÉREZ-IGLESIAS R, MATA I, ORTIZ-GARCIA DE LA FOZ V, MARTÍNEZ-GARCIA O, VALDIZAN EM, VAZQUEZ-BARQUERO JL. Aripiprazole, Ziprasidone, and Quetiapine in the Treatment of First-Episode Nonaffective Psychosis: Results of a 6-Week, Randomized, Flexible-Dose, Open-Label Comparison. J Clin Psychopharmacol. 2013 Apr;33(2):215-20. IF: 3,513 / Q1

10. CRESPO-FACORRO B, GARCIA DE LA FOZ VO, AYESA-ARRIOLA R, PÉREZ-IGLESIAS R, MATA I, SUAREZ-PINILLA P, TABARES-SEISDEDOS R, VÁZQUEZ-BARQUERO JL. Prediction of acute clinical response following a first episode of non affective psychosis: Results of a cohort of 375 patients from the Spanish PAFIP study. Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jul;44:162-7. IF: 3,552 / Q1

11. CRESPO-FACORRO B, ORTIZ-GARCÍA DE LA FOZ V, MATA I, AYESA-ARRIOLA R, SUAREZ-PINILLA P, VALDIZAN EM, VÁZQUEZ-BARQUERO JL, PÉREZ-IGLESIAS R. Aripiprazole, Ziprasidone and Quetiapine in the treatment of first-episode nonaffective psychosis: A 12-week randomized, flexible-dose, open-label trial. Schizophr Res. 2013 Jul;147(2-3):375-82. IF: 4,59 / Q1

12. DE LA SERNA E, ANDRÉS-PERPIÑÁ S, PUIG O, BAEZA I, BOMBIN I, BARTRÉS-FAZ D, ARANGO C, GONZALEZ-PINTO A, PARELLADA M, MAYORAL M, GRAELL M, OTERO S, GUARDIA J, CASTRO-FORNIELES J. Cognitive reserve as a predictor of two year neuropsychological performance in early onset first-episode schizophrenia. Schizophr Res. 2013 Jan;143(1):125-31. IF: 4,59 / Q1

13. DÍAZ I, PELAYO-TERÁN JM, PÉREZ-IGLESIAS R, MATA I, TABARÉS-SEISDEDOS R, SUÁREZ-PINILLA P, VÁZQUEZ-BARQUERO JL, CRESPO-FACORRO B. Predictors of clinical remission following a first episode of non-affective psychosis: Sociodemographics, premorbid and clinical variables. Psychiatry Res. 2013 Apr 30;206(2-3):181-7. IF: 2,456 / Q2

14. GÓMEZ-BENITO J, GUILERA G, PINO O, ROJO E, TABARÉS-SEISDEDOS R, SAFONT G, MARTÍNEZ-ARÁN A, FRANCO M, CUESTA MJ, CRESPO-FACORRO B, BERNARDO M, VIETA E, PURDON SE, MESA F, REJAS J. The screen for cognitive impairment in psychiatry: diagnostic-specific standardization in psychiatric ill patients. BMC Psychiatry. 2013 May 6;13(1):127. IF: 2,233 / Q2

15. MARTINO J, GOMEZ E, BILBAO JL, DUEÑAS JC, VÁZQUEZ-BARQUERO A. Cost-utility of maximal safe resection of WHO grade II gliomas within eloquent areas. Acta Neurochir (Wien). 2013 Jan;155(1):41-50. IF: 1,546 / Q2

16. NAVARRO B, SÁNCHEZ M, HERRÁN A, SIERRA-BIDDLE D. Relationship between personality traits and panic disorder. Actas Esp Psiquiatr. 2013 Jan;41(1):27-32. IF: 0,452 / Q4

Page 3: PUBLICACIONES EN REVISTAS NACIONALES E INTERNACIONALES · g, tabares-seisdedos r, ayuso-mateos jl, vÁzquez-barquero jl, crespo- FACORRO B. Predictors of neurocognitive impairment

UN

IDAD

DE

INVE

STIG

ACIÓ

N E

N P

SIQ

UIA

TRÍA

DE

CAN

TABR

IA |

Hos

pita

l Uni

vers

itario

"M

arqu

és d

e Va

ldec

illa"

| Se

rvic

io d

e Ps

iqui

atría

Resi

denc

ia C

anta

bria

, pla

nta

12.ª

Este

| Av

da. C

arde

nal H

erre

ra O

ria, s

/n.

| 390

11 S

ANTA

ND

ER, C

anta

bria

, Spa

in

Tel.:

(+34

) 942

-202

545

| Fax

: (+3

4) 9

42-2

0344

7 | e

-mai

l: ui

pcs1

1@hu

mv.

es

PUBLICACIONES EN REVISTAS NACIONALES E INTERNACIONALES

Página 3 de 15

17. NOGUERA A, BALLESTA P, BAEZA I, ARANGO C, DE LA SERNA E, GONZÁLEZ-PINTO A, PARELLADA M, GRAELL M, MORENO C, OTERO S, CASTRO-FORNIELES J. Twenty-Four Months of Antipsychotic Treatment in Children and Adolescents With First Psychotic Episode: Discontinuation and Tolerability. J Clin Psychopharmacol. 2013 Aug;33(4):463-471. IF: 3,513 / Q1

18. PAYÁ B, RODRÍGUEZ-SÁNCHEZ JM, OTERO S, MUÑOZ P, CASTRO-FORNIELES J, PARELLADA M, GONZALEZ-PINTO A, SOUTULLO C, BAEZA I, RAPADO-CASTRO M, SÁENZ-HERRERO M, MORENO D, ARANGO C. Premorbid impairments in early-onset psychosis: Differences between patients with schizophrenia and bipolar disorder. Schizophr Res. 2013 May;146(1-3):103-10. IF: 4,59 / Q1

19. PRIEDE A, GONZÁLEZ-BLANCH C, HERRÁN A, HOYUELA F. Asociación entre rumiaciones y malestar emocional en pacientes recién diagnosticados de cáncer. Psicooncología. 2013 Jun;10(1):131-40. NO IF

20. RIPKE S, O'DUSHLAINE C, CHAMBERT K, MORAN JL, KÄHLER AK, AKTERIN S, BERGEN SE, COLLINS AL, CROWLEY JJ, FROMER M, KIM Y, LEE SH, MAGNUSSON PK, SANCHEZ N, STAHL EA, WILLIAMS S, WRAY NR, XIA K, BETTELLA F, BORGLUM AD, BULIK-SULLIVAN BK, CORMICAN P, CRADDOCK N, DE LEEUW C, DURMISHI N, GILL M, GOLIMBET V, HAMSHERE ML, HOLMANS P, HOUGAARD DM, KENDLER KS, LIN K, MORRIS DW, MORS O, MORTENSEN PB, NEALE BM, O'NEILL FA, OWEN MJ, MILOVANCEVIC MP, POSTHUMA D, POWELL J, RICHARDS AL, RILEY BP, RUDERFER D, RUJESCU D, SIGURDSSON E, SILAGADZE T, SMIT AB, STEFANSSON H, STEINBERG S, SUVISAARI J, TOSATO S, VERHAGE M, WALTERS JT; MULTICENTER GENETIC STUDIES OF SCHIZOPHRENIA CONSORTIUM, LEVINSON DF, GEJMAN PV, KENDLER KS, LAURENT C, MOWRY BJ, O'DONOVAN MC, OWEN MJ, PULVER AE, RILEY BP, SCHWAB SG, WILDENAUER DB, DUDBRIDGE F, HOLMANS P, SHI J, ALBUS M, ALEXANDER M, CAMPION D, COHEN D, DIKEOS D, DUAN J, EICHHAMMER P, GODARD S, HANSEN M, LERER FB, LIANG KY, MAIER W, MALLET J, NERTNEY DA, NESTADT G, NORTON N, O'NEILL FA, PAPADIMITRIOU GN, RIBBLE R, SANDERS AR, SILVERMAN JM, WALSH D, WILLIAMS NM, WORMLEY B; PSYCHOSIS ENDOPHENOTYPES INTERNATIONAL CONSORTIUM, ARRANZ MJ, BAKKER S, BENDER S, BRAMON E, COLLIER D, CRESPO-FACORRO B, HALL J, IYEGBE C, JABLENSKY A, KAHN RS, KALAYDJIEVA L, LAWRIE S, LEWIS CM, LIN K, LINSZEN DH, MATA I, MCINTOSH A, MURRAY RM, OPHOFF RA, POWELL J, RUJESCU D, VAN OS J, WALSHE M, WEISBROD M, WIERSMA D; WELLCOME TRUST CASE CONTROL CONSORTIUM 2; MANAGEMENT COMMITTEE:, DONNELLY P, BARROSO I, BLACKWELL JM, BRAMON E, BROWN MA, CASAS JP, CORVIN AP, DELOUKAS P, DUNCANSON A, JANKOWSKI J, MARKUS HS, MATHEW CG, PALMER CN, PLOMIN R, RAUTANEN A, SAWCER SJ, TREMBATH RC, VISWANATHAN AC, WOOD NW; DATA AND ANALYSIS GROUP:, SPENCER CC, BAND G, BELLENGUEZ C, FREEMAN C, HELLENTHAL G, GIANNOULATOU E, PIRINEN M, PEARSON RD, STRANGE A, SU Z, VUKCEVIC D, DONNELLY P; DNA, GENOTYPING, DATA QC AND INFORMATICS

Page 4: PUBLICACIONES EN REVISTAS NACIONALES E INTERNACIONALES · g, tabares-seisdedos r, ayuso-mateos jl, vÁzquez-barquero jl, crespo- FACORRO B. Predictors of neurocognitive impairment

UN

IDAD

DE

INVE

STIG

ACIÓ

N E

N P

SIQ

UIA

TRÍA

DE

CAN

TABR

IA |

Hos

pita

l Uni

vers

itario

"M

arqu

és d

e Va

ldec

illa"

| Se

rvic

io d

e Ps

iqui

atría

Resi

denc

ia C

anta

bria

, pla

nta

12.ª

Este

| Av

da. C

arde

nal H

erre

ra O

ria, s

/n.

| 390

11 S

ANTA

ND

ER, C

anta

bria

, Spa

in

Tel.:

(+34

) 942

-202

545

| Fax

: (+3

4) 9

42-2

0344

7 | e

-mai

l: ui

pcs1

1@hu

mv.

es

PUBLICACIONES EN REVISTAS NACIONALES E INTERNACIONALES

Página 4 de 15

GROUP:, LANGFORD C, HUNT SE, EDKINS S, GWILLIAM R, BLACKBURN H, BUMPSTEAD SJ, DRONOV S, GILLMAN M, GRAY E, HAMMOND N, JAYAKUMAR A, MCCANN OT, LIDDLE J, POTTER SC, RAVINDRARAJAH R, RICKETTS M, TASHAKKORI-GHANBARIA A, WALLER MJ, WESTON P, WIDAA S, WHITTAKER P, BARROSO I, DELOUKAS P; PUBLICATIONS COMMITTEE:, MATHEW CG, BLACKWELL JM, BROWN MA, CORVIN AP, MCCARTHY MI, SPENCER CC, BRAMON E, CORVIN AP, O'DONOVAN MC, STEFANSSON K, SCOLNICK E, PURCELL S, MCCARROLL SA, SKLAR P, HULTMAN CM, SULLIVAN PF. Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet. 2013 Oct;45(10):1150-9. IF: 35,209 / Q1 / D1

21. RODRÍGUEZ-SÁNCHEZ JM, AYESA-ARRIOLA R, PÉREZ-IGLESIAS R, PERIAÑEZ JA, MARTINEZ-GARCIA O, GOMEZ-RUIZ E, TABARES-SEISDEDOS R, CRESPO-FACORRO B. Course of cognitive deficits in first episode of non-affective psychosis: A 3-year follow-up study. Schizophr Res. 2013 Oct;150(1):121-8. IF: 4,59 / Q1

22. SAINZ J, MATA I, BARRERA J, PEREZ-IGLESIAS R, VARELA I, ARRANZ MJ, RODRIGUEZ MC, CRESPO-FACORRO B. Inflammatory and immune response genes have significantly altered expression in schizophrenia. Mol Psychiatry. 2013 Oct;18(10):1056-7. IF: 14,897 / Q1 / D1

23. SANCHEZ-GISTAU V, BAEZA I, ARANGO C, GONZÁLEZ-PINTO A, DE LA SERNA E, PARELLADA M, GRAELL M, PAYA B, LLORENTE C, CASTRO-FORNIELES J. Predictors of suicide attempt in early-onset, first-episode psychoses: a longitudinal 24-month follow-up study. J Clin Psychiatry. 2013 Jan;74(1):59-66. IF: 5,812 / Q1

24. SUÁREZ-PINILLA P, ROIZ-SANTIAÑEZ R, DE LA FOZ VO, MATA I, FAÑANAS L, BRAMBILLA P, RUÍZ-PÉREZ E, CRESPO-FACORRO B. BDNF Val66Met variants and brain volumen changes in non-affective psychosis patients and healthy controls: A 3years follow-up study. Prog Neuropsychopharmacol Biol Psychiatry. 2013 Aug;45:201-6. IF: 3,552 / Q1

25. ALVAREZ-JIMENEZ M, PRIEDE A, HETRICK SE, BENDALL S, KILLACKEY E, PARKER AG, MCGORRY PD, GLEESON JF. Risk factors for relapse following treatment for first episode psychosis: a systematic review and meta-analysis of longitudinal studies. Schizophr Res. 2012 Aug;139(1-3):116-28. IF: 4,590 / Q1

26. ARANGO C, RAPADO-CASTRO M, REIG S, CASTRO-FORNIELES J, GONZÁLEZ-PINTO A, OTERO S, BAEZA I, MORENO C, GRAELL M, JANSSEN J, PARELLADA M, MORENO D, BARGALLÓ N, DESCO M. Progressive brain changes in children and adolescents with first-episode psychosis. Arch Gen Psychiatry. 2012 Jan;69(1):16-26. IF: 13,772 / Q1

27. AYESA-ARRIOLA R, PÉREZ-IGLESIAS R, RODRÍGUEZ-SÁNCHEZ JM, MATA I, GÓMEZ-RUIZ E, GARCÍA-UNZUETA M, MARTÍNEZ-GARCÍA O, TABARES-SEISDEDOS R, VÁZQUEZ-BARQUERO JL, CRESPO-FACORRO B. Homocysteine and cognition in

Page 5: PUBLICACIONES EN REVISTAS NACIONALES E INTERNACIONALES · g, tabares-seisdedos r, ayuso-mateos jl, vÁzquez-barquero jl, crespo- FACORRO B. Predictors of neurocognitive impairment

UN

IDAD

DE

INVE

STIG

ACIÓ

N E

N P

SIQ

UIA

TRÍA

DE

CAN

TABR

IA |

Hos

pita

l Uni

vers

itario

"M

arqu

és d

e Va

ldec

illa"

| Se

rvic

io d

e Ps

iqui

atría

Resi

denc

ia C

anta

bria

, pla

nta

12.ª

Este

| Av

da. C

arde

nal H

erre

ra O

ria, s

/n.

| 390

11 S

ANTA

ND

ER, C

anta

bria

, Spa

in

Tel.:

(+34

) 942

-202

545

| Fax

: (+3

4) 9

42-2

0344

7 | e

-mai

l: ui

pcs1

1@hu

mv.

es

PUBLICACIONES EN REVISTAS NACIONALES E INTERNACIONALES

Página 5 de 15

first-episode psychosis patients. Eur Arch Psychiatry Clin Neurosci. 2012 Oct;262(7):557-64. IF: 3,2 / Q1

28. AYUSO-MATEOS JL, BACA-GARCIA E, BOBES J, GINER J, GINER L, PEREZ V, SAIZ PA, SAIZ J, GRUPO RECOMS (HERRAN GÓMEZ A). Recomendaciones preventivas y manejo del comportamiento suicida en España. Rev Psiquiatr Salud Ment (Barc.). 2012 Jan-Feb;5(1):8-23. IF: 0,667 / Q4

29. CARLETTI F, WOOLLEY JB, BHATTACHARYYA S, PEREZ-IGLESIAS R, FUSAR POLI P, VALMAGGIA L, BROOME MR, BRAMON E, JOHNS L, GIAMPIETRO V, WILLIAMS SC, BARKER GJ, MCGUIRE PK. Alterations in White Matter Evident Before the Onset of Psychosis. Schizophr Bull. 2012 Nov;38(6):1170-9. IF: 8,486 / Q1

30. CASEIRO O, PÉREZ-IGLESIAS R, MATA I, MARTÍNEZ-GARCIA O, PELAYO-TERÁN JM, TABARES-SEISDEDOS R, ORTIZ-GARCÍA DE LA FOZ V, VÁZQUEZ-BARQUERO JL, CRESPO-FACORRO B. Predicting relapse after a first episode of non-affective psychosis: A three-year follow-up study. J Psychiatr Res. 2012 Aug;46(8):1099–105. IF: 4,066 / Q1

31. CRESPO-FACORRO B, PÉREZ-IGLESIAS R, MATA I, MARTÍNEZ-GARCIA O, ORTIZ V, PELAYO-TERÁN JM, VALDIZAN E, VAZQUEZ-BARQUERO JL. Long-term (3-year) effectiveness of haloperidol, risperidone and olanzapine: results of a randomized, flexible-dose, open-label comparison in first-episode nonaffective psychosis. Psychopharmacology (Berl). 2012 Jan;219(1):225-33. IF: 4,061 / Q1

32. GONZÁLEZ S, ARTAL J, GÓMEZ E, CABALLERO P, MAYORAL J, MORENO T, ÁLVAREZ-JIMÉNEZ M, GOOK S, VILLACORTA MC, HIGUERA A, VÁZQUEZ-BARQUERO JL. Early intervention in Bipolar Disorder: the Jano program at Hospital Universitario Marqués de Valdecilla. Actas Esp Psiquiatr. 2012 Mar;40(2):51-6. IF: 0,452 / Q4

33. GONZÁLEZ-BLANCH C, PRIEDE A, RODRÍGUEZ-SÁNCHEZ JM, PEREZ-IGLESIAS R, VÁZQUEZ-BARQUERO JL, CRESPO-FACORRO B. Identifying attentional deficits in people with first-episode psychosis with the Scale for the Assessment of Negative Symptoms attention subscale: is it possible? Compr Psychiatry. 2012 Aug;53(6):701-5. IF: 2,376 / Q2

34. GONZALEZ-PINTO A, MARTINEZ-CENGOTITABENGOA M, ARANGO C, BAEZA I, OTERO-CUESTA S, GRAELL-BERNA M, SOUTULLO C, LEZA JC, MICÓ JA. Antioxidant defense system and family environment in adolescents with family history of psychosis. BMC Psychiatry. 2012 Nov 16;12(1):200. IF: 2,233 / Q2

35. GUILERA G, GÓMEZ-BENITO J, PINO O, ROJO JE, CUESTA MJ, MARTÍNEZ-ARÁN A, SAFONT G, TABARÉS-SEISDEDOS R, VIETA E, BERNARDO M, CRESPO-FACORRO B, FRANCO M, REJAS J. Utility of the World Health Organization Disability Assessment Schedule II in schizophrenia. Schizophr Res. 2012 Jul;138(2–3):240-7. IF: 4,59 / Q1

Page 6: PUBLICACIONES EN REVISTAS NACIONALES E INTERNACIONALES · g, tabares-seisdedos r, ayuso-mateos jl, vÁzquez-barquero jl, crespo- FACORRO B. Predictors of neurocognitive impairment

UN

IDAD

DE

INVE

STIG

ACIÓ

N E

N P

SIQ

UIA

TRÍA

DE

CAN

TABR

IA |

Hos

pita

l Uni

vers

itario

"M

arqu

és d

e Va

ldec

illa"

| Se

rvic

io d

e Ps

iqui

atría

Resi

denc

ia C

anta

bria

, pla

nta

12.ª

Este

| Av

da. C

arde

nal H

erre

ra O

ria, s

/n.

| 390

11 S

ANTA

ND

ER, C

anta

bria

, Spa

in

Tel.:

(+34

) 942

-202

545

| Fax

: (+3

4) 9

42-2

0344

7 | e

-mai

l: ui

pcs1

1@hu

mv.

es

PUBLICACIONES EN REVISTAS NACIONALES E INTERNACIONALES

Página 6 de 15

36. JORGE RE, ACION L, WHITE T, TORDESILLAS-GUTIERREZ D, PIERSON R, CRESPO-FACORRO B, MAGNOTTA VA. White matter abnormalities in veterans with mild traumatic brain injury. Am J Psychiatry. 2012 Dec 1;169(12):1284-91. IF: 14,721 / Q1

37. MARTINO J, GÓMEZ E, GARCÍA-CASTAÑO A, MARCO DE LUCAS E, MALDONADO S, MARTÍN-LÁEZ R, POMPOSO-GAZTELU I, VÁZQUEZ-BARQUERO A. [WHO grade II gliomas: review of the current management.]. Neurocirugia (Astur). 2012 May;23(3):104-11. Spanish. IF: 0,343 / Q4

38. MARTINO J, GÓMEZ E, MARCO DE LUCAS E, MARTÍNEZ M, OCON R, VALLE-FOLGUERAL JM, VEGA M, VÁZQUEZ-BARQUERO A. [Controversy in the management of WHO grade II gliomas in eloquent brain areas: recent literature review]. Neurocirugia (Astur). 2012 Mar;23(2):70-8. Spanish. IF: 0,343 / Q4

39. MAYORAL M, BOMBÍN I, CASTRO-FORNIELES J, GONZÁLEZ-PINTO A, OTERO S, PARELLADA M, MORENO D, BAEZA I, GRAELL M, RAPADO M, ARANGO C. Longitudinal study of neurological soft signs in first-episode early-onset psychosis. J Child Psychol Psychiatry. 2012 Mar;53(3):323-331. IF: 5,422 / Q1

40. PELAYO-TERAN JM, SUÁREZ-PINILLA P, CHADI N, CRESPO-FACORRO B. Gene-Environment Interactions Underlying the Effect of Cannabis in First Episode Psychosis. Curr Pharm Des. 2012 Nov;18(32):5024-35. IF: 3,311 / Q1

41. PÉREZ-IGLESIAS R, MATA I, MARTÍNEZ-GARCÍA O, GARCIA-UNZUETA MT, AMADO JA, VALDIZÁN EM, VÁZQUEZ-BARQUERO JL, CRESPO-FACORRO B. Long-Term Effect of Haloperidol, Olanzapine, and Risperidone on Plasma Prolactin Levels in Patients With First-Episode Psychosis. J Clin Psychopharmacol. 2012 Dec;32(6):804-808. IF: 3,513 / Q1

42. ROIZ-SANTIÁÑEZ R, PÉREZ-IGLESIAS R, ORTÍZ-GARCÍA DE LA FOZ V, TORDESILLAS-GUTIÉRREZ D, MATA I, GONZÁLEZ-MANDLY A, PAZOS A, TABARÉS-SEISDEDOS R, VÁZQUEZ-BARQUERO JL, CRESPO-FACORRO B. One year longitudinal study of the straight gyrus morphometry in first-episode schizophrenia-spectrum patients. Psychiatry Res-Neuroim. 2012 Apr 30;202(1):80-3. IF: 3,364 / Q2

43. ROIZ-SANTIÁÑEZ R, TORDESILLAS-GUTIÉRREZ D, ORTÍZ-GARCÍA DE LA FOZ V, AYESA-ARRIOLA R, GUTIÉRREZ A, TABARÉS-SEISDEDOS R, VÁZQUEZ-BARQUERO JL, CRESPO-FACORRO B. Effect of antipsychotic drugs on cortical thickness. A randomized controlled one-year follow-up study of haloperidol, risperidone and olanzapine. Schizophr Res. 2012 Oct;141(1):22-8. IF: 4,59 / Q1

44. SUÁREZ-FERNÁNDEZ D, VÁZQUEZ-BARQUERO A, GÓMEZ E, MARCO DE LUCAS E, LOPEZ LA, MATO D, MARTÍN-LÁEZ R, OCON R, MARTINO J. [Efficacy and safety of intraoperative electrical stimulation mapping for resection of WHO grade II and III gliomas within eloquent areas.]. Med Clin (Barc). 2012 Oct 6;139(8):331-40. Spanish. IF: 1,399 / Q2

Page 7: PUBLICACIONES EN REVISTAS NACIONALES E INTERNACIONALES · g, tabares-seisdedos r, ayuso-mateos jl, vÁzquez-barquero jl, crespo- FACORRO B. Predictors of neurocognitive impairment

UN

IDAD

DE

INVE

STIG

ACIÓ

N E

N P

SIQ

UIA

TRÍA

DE

CAN

TABR

IA |

Hos

pita

l Uni

vers

itario

"M

arqu

és d

e Va

ldec

illa"

| Se

rvic

io d

e Ps

iqui

atría

Resi

denc

ia C

anta

bria

, pla

nta

12.ª

Este

| Av

da. C

arde

nal H

erre

ra O

ria, s

/n.

| 390

11 S

ANTA

ND

ER, C

anta

bria

, Spa

in

Tel.:

(+34

) 942

-202

545

| Fax

: (+3

4) 9

42-2

0344

7 | e

-mai

l: ui

pcs1

1@hu

mv.

es

PUBLICACIONES EN REVISTAS NACIONALES E INTERNACIONALES

Página 7 de 15

45. VÁZQUEZ BOURGON J, SALVADOR CARULLA L, VÁZQUEZ-BARQUERO JL. Community alternatives to acute inpatient care for severe psychiatric patients. Actas Esp Psiquiatr. 2012 Nov;40(6):323-32. IF: 0,452 / Q4

46. ALVAREZ-JIMÉNEZ M, PARKER AG, HETRICK SE, MCGORRY PD, GLEESON JF. Preventing the Second Episode: A Systematic Review and Meta-analysis of Psychosocial and Pharmacological Trials in First-Episode psychosis. Schizophr Bull. 2011 May;37(3):619-30. IF: 8,273 / Q1

47. AYESA-ARRIOLA R, RODRÍGUEZ-SÁNCHEZ JM, MORELLI C, PELAYO-TERÁN JM, PÉREZ-IGLESIAS R, MATA I, MARTÍNEZ-GARCIA O, PARDO-GARCIA G, VAZQUEZ-BARQUERO JL, CRESPO-FACORRO B. Insight dimensions in first-episode psychosis patients: clinical, cognitive, pre-morbid and socio-demographic correlates. Early Interv Psychiatry. 2011 May;5(2):140-49. IF: 1,169 / Q3

48. BERNARDO M, VIETA E, SÁIZ RUIZ J, RICO-VILLADEMOROS F, ÁLAMO C, BOBES J, GRUPO RECAP (CRESPO-FACORRO B). Recomendaciones para el cambio de antipsicóticos. Posicionamiento de la Sociedad Española de Psiquatría y Sociedad Española de Psiquiatría Biológica. Rev Psiquiatr Salud Ment (Barc.). 2011 Sep;4(3):150-68. IF: 0,308 / Q4

49. CASTRO-FORNIELES J, BAEZA I, DE LA SERNA E, GONZALEZ-PINTO A, PARELLADA M, GRAELL M, MORENO D, OTERO S, ARANGO C. Two-year diagnostic stability in early-onset first-episode psychosis. J Child Psychol Psychiatry. 2011 Oct;52(10):1089-98. IF: 4,360 / Q1

50. CRESPO-FACORRO B, ROIZ-SANTIÁÑEZ R, PÉREZ-IGLESIAS R, MATA I, RODRÍGUEZ-SÁNCHEZ JM, TORDESILLAS-GUTIÉRREZ D, ORTÍZ-GARCÍA DE LA FOZ V, TABARÉS-SEISDEDOS R, SÁNCHEZ E, ANDREASEN N, MAGNOTTA V, VÁZQUEZ-BARQUERO JL. Sex-specific variation of MRI-based cortical morphometry in adult healthy volunteers: The effect on cognitive functioning. Prog Neuropsychopharmacol Biol Psychiatry. 2011 Mar 30;35(2):616-23. IF: 2,877 / Q2

51. CRESPO-FACORRO B, PÉREZ-IGLESIAS RO, MATA I, RAMIREZ-BONILLA M, MARTÍNEZ-GARCIA O, PARDO-GARCIA G, CASEIRO O, PELAYO-TERÁN JM, VÁZQUEZ-BARQUERO JL. Effectiveness of haloperidol, risperidone and olanzapine in the treatment of first-episode non-affective psychosis: results of a randomized, flexible-dose, open-label 1-year follow-up comparison. J Psychopharmacol. 2011 Jun;25(6):744-54. IF: 3,801 / Q1

52. CRESPO-FACORRO B, PÉREZ-IGLESIAS R, MATA I, CASEIRO O, MARTINEZ GARCIA O, PARDO G, RAMIREZ BONILLA ML, PELAYO TERAN JM, VÁZQUEZ-BARQUERO JL. Relapse prevention and remission attainment in first-episode non-affective psychosis. A randomized controlled 1-year follow-up comparison of haloperidol, risperidone and olanzapine. J Psychiatr Res. 2011 Jun; 45(6):763-9. IF: 3,827 / Q1

Page 8: PUBLICACIONES EN REVISTAS NACIONALES E INTERNACIONALES · g, tabares-seisdedos r, ayuso-mateos jl, vÁzquez-barquero jl, crespo- FACORRO B. Predictors of neurocognitive impairment

UN

IDAD

DE

INVE

STIG

ACIÓ

N E

N P

SIQ

UIA

TRÍA

DE

CAN

TABR

IA |

Hos

pita

l Uni

vers

itario

"M

arqu

és d

e Va

ldec

illa"

| Se

rvic

io d

e Ps

iqui

atría

Resi

denc

ia C

anta

bria

, pla

nta

12.ª

Este

| Av

da. C

arde

nal H

erre

ra O

ria, s

/n.

| 390

11 S

ANTA

ND

ER, C

anta

bria

, Spa

in

Tel.:

(+34

) 942

-202

545

| Fax

: (+3

4) 9

42-2

0344

7 | e

-mai

l: ui

pcs1

1@hu

mv.

es

PUBLICACIONES EN REVISTAS NACIONALES E INTERNACIONALES

Página 8 de 15

53. CRESPO-FACORRO B, ROIZ SANTIAÑEZ R, PEREZ-IGLESIAS R, RODRIGUEZ-SANCHEZ JM, MATA I, TORDESILLAS GUTIERREZ D, SANCHEZ E, TABARES SEISDEDOS R, ANDREASEN N, MAGNOTTA V, VAZQUEZ-BARQUERO JL. Global and regional cortical thinning in first-episode psychosis patients: relationships with clinical and cognitive features. Psychol Med. 2011 Jul;41(7):1449-60. IF: 5,200 / Q1

54. CUESTA MJ, PINO O, GUILERA G, ROJO JE, GÓMEZ-BENITO J, PURDON SE, FRANCO M, MARTÍNEZ-ARÁN A, SEGARRA N, TABARÉS-SEISDEDOS R, VIETA E, BERNARDO M, CRESPO-FACORRO B, MESA F, REJAS J. Brief cognitive assessment instruments in schizophrenia and bipolar patients, and healthy control subjects: A comparison study between the Brief Cognitive Assessment Tool for Schizophrenia (B-CATS) and the Screen for Cognitive Impairment in Psychiatry (SCIP). Schizophr Res. 2011 Aug;130(1-3):137-42. IF: 4,374 / Q1

55. DIAZ FJ, PEREZ-IGLESIAS R, MATA I, MARTÍNEZ-GARCIA O, VÁZQUEZ-BARQUERO JL, DE LEON J, CRESPO-FACORRO B. Using structural equations to test for a direct effect of some antipsychotics on triglyceride levels in drug-naïve first-episode psychosis patients. Schizophr Res. 2011 Sep;131(1-3):82-9. IF: 4,374 / Q1

56. FUSAR-POLI P, CROSSLEY N, WOOLLEY J, CARLETTI F, PEREZ-IGLESIAS R, BROOME M, JOHNS L, TABRAHAM P, BRAMON E, MCGUIRE P. Gray matter alterations related to P300 abnormalities in subjects at high risk for psychosis: Longitudinal MRI-EEG study. Neuroimage. 2011 Mar 1;55(1):320-8. IF: 5,932 / Q1

57. FUSAR-POLI P, CROSSLEY N, WOOLLEY J, CARLETTI F, PEREZ-IGLESIAS R, BROOME M, JOHNS L, TABRAHAM P, BRAMON E, MCGUIRE P. White matter alterations related to P300 abnormalities in individuals at high risk for psychosis: an MRI-EEG study. J Psychiatr Neurosci. 2011 Jul;36(4):239-48. IF: 4,893 / Q1

58. GONZÁLEZ-BLANCH C, PÉREZ-IGLESIAS R, RODRÍGUEZ-SÁNCHEZ JM, PARDO-GARCÍA G, MARTÍNEZ-GARCÍA O, VÁZQUEZ-BARQUERO JL, CRESPO-FACORRO B. A Digit Symbol Coding Task as a Screening Instrument for Cognitive Impairment in First-Episode Psychosis. Arch Clin Neuropsychol. 2011 Feb;26(1):48-58. IF: 2,304 / Q2

59. GONZÁLEZ-BLANCH C, ALVAREZ-JIMÉNEZ M. Review: family interventions reduce relapse or hospitalisation in people with schizophrenia. Evid Based Ment Health. 2011 Nov;14(4):115. IF: ?,??? / Q?

60. GONZÁLEZ-PINTO A, DE AZÚA SR, IBÁÑEZ B, OTERO-CUESTA S, CASTRO-FORNIELES J, GRAELL-BERNA M, UGARTE A, PARELLADA M, MORENO D, SOUTULLO C, BAEZA I, ARANGO C. Can positive family factors be protective against the development of psychosis? Psychiatry Res. 2011 Mar 30;186(1):28-33. IF: 2,803 / Q2

Page 9: PUBLICACIONES EN REVISTAS NACIONALES E INTERNACIONALES · g, tabares-seisdedos r, ayuso-mateos jl, vÁzquez-barquero jl, crespo- FACORRO B. Predictors of neurocognitive impairment

UN

IDAD

DE

INVE

STIG

ACIÓ

N E

N P

SIQ

UIA

TRÍA

DE

CAN

TABR

IA |

Hos

pita

l Uni

vers

itario

"M

arqu

és d

e Va

ldec

illa"

| Se

rvic

io d

e Ps

iqui

atría

Resi

denc

ia C

anta

bria

, pla

nta

12.ª

Este

| Av

da. C

arde

nal H

erre

ra O

ria, s

/n.

| 390

11 S

ANTA

ND

ER, C

anta

bria

, Spa

in

Tel.:

(+34

) 942

-202

545

| Fax

: (+3

4) 9

42-2

0344

7 | e

-mai

l: ui

pcs1

1@hu

mv.

es

PUBLICACIONES EN REVISTAS NACIONALES E INTERNACIONALES

Página 9 de 15

61. MAYORAL VAN SON J, MORENO CALLE T, ARTAL SIMÓN J, GÓMEZ RUIZ E, CABALLERO P, GONZÁLEZ S, VILLACORTA C, VÁZQUEZ-BARQUERO JL. [Early intervention in Bipolar Depression: Interferences from a descriptive study]. Norte Salud Ment. 2011 Jun; IX(40):38-45. NO IF

62. MICO JA, ROJAS-CORRALES MO, GIBERT-RAHOLA J, PARELLADA M, MORENO D, FRAGUAS D, GRAELL M, GIL J, IRAZUSTA J, CASTRO FORNIELES J, SOUTULLO C, ARANGO C, OTERO S, NAVARRO A, BAEZA I, MARTINEZ-CENGOTITABENGOA M, GONZALEZ-PINTO A. Reduced antioxidant defense in early onset first-episode psychosis: a case-control study. BMC Psychiatry. 2011 Feb 14;11(1):26. IF: 2,891 / Q2

63. OTERO S, MORENO-INIGUEZ M, PAYÁ B, CASTRO-FORNIELES J, GONZALEZ-PINTO A, BAEZA I, MAYORAL M, GRAELL M, ARANGO-LÓPEZ C. Twelve-month follow-up of family communication and psychopathology in children and adolescents with a first psychotic episode (CAFEPS study). Psychiatry Res. 2011 Jan 30;185(1-2):72-7. IF: 2,803 / Q2

64. PARELLADA M, BOADA L, FRAGUAS D, REIG S, CASTRO-FORNIELES J, MORENO D, GONZALEZ-PINTO A, OTERO S, RAPADO-CASTRO M, GRAELL M, BAEZA I, ARANGO C. Trait and State Attributes of Insight in First Episodes of Early-Onset Schizophrenia and Other Psychoses: A 2-Year Longitudinal Study. Schizophr Bull. 2011 Jan;37(1):38-51. IF: 8,273 / Q1

65. PELAYO-TERÁN JM, PÉREZ-IGLESIAS R, VÁZQUEZ-BOURGON J, MATA I, CARRASCO-MARÍN E, VÁZQUEZ-BARQUERO JL, CRESPO-FACORRO B. Catechol-O-methyltransferase Val158Met polymorphism and negative symptoms after acute antipsychotic treatment in first-episode non-affective psychosis. Psychiatry Res. 2011 Jan; 185(1-2):286-9. IF: 2,803 / Q2

66. RODRÍGUEZ B, PRIEDE A, MAESO A, ARRANZ H, PALAO A. Cambios psicológicos e intervenciones basadas en mindfulness para los supervivientes de un cáncer. Psicooncología. 2011 Dec;8(1):7-20.

67. REIG S, PARELLADA M, CASTRO-FORNIELES J, JANSSEN J, MORENO D, BAEZA I, BARGALLÓ N, GONZÁLEZ-PINTO A, GRAELL M, ORTUÑO F, OTERO S, ARANGO C, DESCO M. Multicenter Study of Brain Volume Abnormalities in Children and Adolescent-Onset Psychosis. Schizophr Bull. 2011 Nov;37(6):1270-80. IF: 8,273 / Q1

68. ROIZ-SANTIÁÑEZ R, PÉREZ-IGLESIAS R, DE LA FOZ VO, TORDESILLAS-GUTIÉRREZ D, MATA I, DE LUCAS EM, PAZOS A, TABARÉS-SEISDEDOS R, VÁZQUEZ-BARQUERO JL, CRESPO-FACORRO B. Straight gyrus morphology in first-episode schizophrenia-spectrum patients. Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jan 15;35(1):84-90. IF: 2,877 / Q2

Page 10: PUBLICACIONES EN REVISTAS NACIONALES E INTERNACIONALES · g, tabares-seisdedos r, ayuso-mateos jl, vÁzquez-barquero jl, crespo- FACORRO B. Predictors of neurocognitive impairment

UN

IDAD

DE

INVE

STIG

ACIÓ

N E

N P

SIQ

UIA

TRÍA

DE

CAN

TABR

IA |

Hos

pita

l Uni

vers

itario

"M

arqu

és d

e Va

ldec

illa"

| Se

rvic

io d

e Ps

iqui

atría

Resi

denc

ia C

anta

bria

, pla

nta

12.ª

Este

| Av

da. C

arde

nal H

erre

ra O

ria, s

/n.

| 390

11 S

ANTA

ND

ER, C

anta

bria

, Spa

in

Tel.:

(+34

) 942

-202

545

| Fax

: (+3

4) 9

42-2

0344

7 | e

-mai

l: ui

pcs1

1@hu

mv.

es

PUBLICACIONES EN REVISTAS NACIONALES E INTERNACIONALES

Página 10 de 15

69. TABARÉS-SEISDEDOS R, DUMONT N, BAUDOT A, VALDERAS JM, CLIMENT J, VALENCIA A, CRESPO-FACORRO B, VIETA E, GÓMEZ-BENEYTO M, MARTÍNEZ S, RUBENSTEIN JL. No paradox, no progress: inverse cancer comorbility in people with other complex diseases. Lancet Oncol. 2011 Jun;12(6):604-8. IF: 22,589 / Q1

70. VÁZQUEZ-BARQUERO JL. Hallucinations: A Guide to Treatment and Management. Psychiatrist. 2011 Oct;35(10):399. IF: ? / Q?

71. ÁLVAREZ-JIMÉNEZ M, MARTÍNEZ-GARCÍA O, PÉREZ-IGLESIAS R, RAMÍREZ ML, VÁZQUEZ-BARQUERO JL, CRESPO-FACORRO B. Prevention of antipsychotic-induced weight gain with early behavioural intervention in first-episode psychosis: 2-year results of a randomized controlled trial. Schizophr Res. 2010; 116(1):16-9. IF: 4,458 / Q1

72. BALDWIN DS, ALLGULANDER C, ALTAMURA AC, ANGST J, BANDELOW B, DEN BOER J, BOYER P, DAVIES S, DELL'OSSO B, ERIKSSON E, FINEBERG N, FREDRIKSON M, HERRAN A, MARON E, METSPALU A, NUTT D, VAN DER WEE N, VAZQUEZ BARQUERO JL, ZOHAR J. Manifesto for a European Anxiety Disorders Research Network. Eur Neuropsychopharmacol. 2010 Jun;20(6):426-32. IF: 3,684 / Q1

73. CRESPO-FACORRO B, ROIZ-SANTIÁÑEZ R, QUINTERO C, PÉREZ-IGLESIAS R, TORDESILLAS-GUTIÉRREZ D, MATA I, RODRÍGUEZ-SÁNCHEZ JM, GUTIÉRREZ A, VÁZQUEZ-BARQUERO JL. Insular cortex morphometry in first-episode schizophrenia-spectrum patients: Diagnostic specificity and clinical correlations. J Psychiatr Res. 2010;44(5):314-20. IF: 3,723 / Q1

74. DE LA SERNA E, MAYORAL M, BAEZA I, ARANGO C, ANDRÉS P, BOMBIN I, GONZÁLEZ C, RAPADO M, ROBLES O, RODRÍGUEZ-SÁNCHEZ JM, ZABALA A, CASTRO-FORNIELES J. Cognitive functioning in children and adolescents in their first episode of psychosis: differences between previous cannabis users and nonusers. J Nerv Ment Dis. 2010 Feb;198(2):159-62. IF: 1,771 / Q3

75. DIAZ FJ, PÉREZ-IGLESIAS R, MATA I, MARTÍNEZ-GARCIA O, VÁZQUEZ-BARQUERO JL, DE LEON J, CRESPO-FACORRO B. Possible effects of some antipsychotic drugs on C-reactive protein in a drug-naïve psychotic sample. Schizophr Res. 2010 Aug; 121(1-3):207-12. IF: 4,458 / Q1

76. GONZÁLEZ-BLANCH C, MARTÍN-MUÑOZ V, PARDO-GARCÍA G, MARTÍNEZ-GARCÍA O, ALVAREZ-JIMÉNEZ M, RODRÍGUEZ-SÁNCHEZ JM, VÁZQUEZ-BARQUERO JL, CRESPO-FACORRO B. Effects of family psychoeducation on expressed emotion and burden of care in first-episode psychosis: a prospective observational study. Span J Psychol. 2010 May; 13(1):389-95. IF: 0,704 / Q3

77. GONZALEZ-BLANCH C, RODRIGUEZ-SANCHEZ JM, PEREZ-IGLESIAS R, PARDO-GARCIA G, MARTINEZ-GARCIA O, VAZQUEZ-BARQUERO JL, CRESPO-FACORRO B. First-episode schizophrenia patients neuropsychologically within the normal

Page 11: PUBLICACIONES EN REVISTAS NACIONALES E INTERNACIONALES · g, tabares-seisdedos r, ayuso-mateos jl, vÁzquez-barquero jl, crespo- FACORRO B. Predictors of neurocognitive impairment

UN

IDAD

DE

INVE

STIG

ACIÓ

N E

N P

SIQ

UIA

TRÍA

DE

CAN

TABR

IA |

Hos

pita

l Uni

vers

itario

"M

arqu

és d

e Va

ldec

illa"

| Se

rvic

io d

e Ps

iqui

atría

Resi

denc

ia C

anta

bria

, pla

nta

12.ª

Este

| Av

da. C

arde

nal H

erre

ra O

ria, s

/n.

| 390

11 S

ANTA

ND

ER, C

anta

bria

, Spa

in

Tel.:

(+34

) 942

-202

545

| Fax

: (+3

4) 9

42-2

0344

7 | e

-mai

l: ui

pcs1

1@hu

mv.

es

PUBLICACIONES EN REVISTAS NACIONALES E INTERNACIONALES

Página 11 de 15

limits: evidence of deterioration in speed of processing. Schizophr Res. 2010 Jun;119(1-3):18-26. IF: 4,458 / Q1

78. GONZÁLEZ-BLANCH C, PEREZ-IGLESIAS R, PARDO-GARCÍA G, RODRÍGUEZ-SÁNCHEZ JM, MARTÍNEZ-GARCÍA O, VÁZQUEZ-BARQUERO JL, CRESPO-FACORRO B. Prognostic value of cognitive functioning for global functional recovery in first-episode schizophrenia. Psychol Med. 2010;40(6):935-44. IF: 5,012 / Q1

79. GLAHN DC, ROBINSON JL, TORDESILLAS-GUTIERREZ D, MONKUL ES, HOLMES MK, GREEN MJ, BEARDEN CE. Fronto-temporal dysregulation in asymptomatic bipolar I patients: a paired associate functional MRI study. Hum Brain Mapp. 2010 Jul; 31(7):1041-51. IF: 6,256 / Q1

80. LAIRD AR, ROBINSON JL, MCMILLAN KM, TORDESILLAS-GUTIÉRREZ D, MORAN ST, GONZALES SM, RAY KL, FRANKLIN C, GLAHN DC, FOX PT, LANCASTER JL. Comparison of the disparity between Talairach and MNI coordinates in functional neuroimaging data: Validation of the Lancaster transform. Neuroimage. 2010 Jun; 51(2):677-83. IF: 5,739 / Q1

81. MATA I, PEREZ-IGLESIAS R, ROIZ-SANTIANEZ R, TORDESILLAS-GUTIERREZ D, GONZALEZ-MANDLY A, BERJA A, VAZQUEZ-BARQUERO JL, CRESPO-FACORRO B. Additive effect of NRG1 and DISC1 genes on lateral ventricle enlargement in first episode schizophrenia. Neuroimage. 2010 Nov; 53(3):1016-22. IF: 5,739 / Q1

82. MATA I, PEREZ-IGLESIAS R, ROIZ-SANTIANEZ R, TORDESILLAS-GUTIERREZ D, PAZOS A, GUTIERREZ A, VAZQUEZ-BARQUERO JL, CRESPO-FACORRO B. Gyrification brain abnormalities associated with adolescence and early-adulthood cannabis use. Brain Res. 2010; 1317:297-304. IF: 2,463 / Q3

83. NUEVO R, LEIGHTON C, DUNN G, DOWRICK C, LEHTINEN V, DALGARD OS, CASEY P, VÁZQUEZ-BARQUERO JL, AYUSO-MATEOS JL. Impact of severity and type of depression on quality of life in cases identified in the community. Psychol Med. 2010 Dec;40(12):2069-77. IF: 5,012 / Q1

84. OLMOS JM, VALERO C, DEL BARRIO AG, AMADO JA, HERNÁNDEZ JL, MENÉNDEZ-ARANGO J, GONZÁLEZ-MACÍAS J. Time course of bone loss in patients with anorexia nervosa. Int J Eat Disord. 2010 Sep;43(6):537-42. IF: 2,797 / Q2

85. PELAYO-TERAN JM, PEREZ-IGLESIAS R, MATA I, CARRASCO-MARÍN E, VAZQUEZ-BARQUERO JL, CRESPO-FACORRO B. Catechol-O-Methyltransferase (COMT) Val158Met variations and cannabis use in First-Episode non-afective Psychosis: Clinical-onset implications. Psychiatry Res. 2010 Oct; 179(3):291-6. IF: 2,373 / Q2

86. PÉREZ-IGLESIAS R, TORDESILLAS-GUTIÉRREZ D, BARKER GJ, MCGUIRE PK, ROIZ-SANTIAÑEZ R, MATA I, DE LUCAS EM, QUINTANA F, VAZQUEZ-BARQUERO JL, CRESPO-FACORRO B. White matter defects in first episode psychosis patients: a voxelwise analysis of diffusion tensor imaging. Neuroimage. 2010; 49(1):199-204. IF: 5,739 / Q1

Page 12: PUBLICACIONES EN REVISTAS NACIONALES E INTERNACIONALES · g, tabares-seisdedos r, ayuso-mateos jl, vÁzquez-barquero jl, crespo- FACORRO B. Predictors of neurocognitive impairment

UN

IDAD

DE

INVE

STIG

ACIÓ

N E

N P

SIQ

UIA

TRÍA

DE

CAN

TABR

IA |

Hos

pita

l Uni

vers

itario

"M

arqu

és d

e Va

ldec

illa"

| Se

rvic

io d

e Ps

iqui

atría

Resi

denc

ia C

anta

bria

, pla

nta

12.ª

Este

| Av

da. C

arde

nal H

erre

ra O

ria, s

/n.

| 390

11 S

ANTA

ND

ER, C

anta

bria

, Spa

in

Tel.:

(+34

) 942

-202

545

| Fax

: (+3

4) 9

42-2

0344

7 | e

-mai

l: ui

pcs1

1@hu

mv.

es

PUBLICACIONES EN REVISTAS NACIONALES E INTERNACIONALES

Página 12 de 15

87. PÉREZ-IGLESIAS R, TORDESILLAS-GUTIÉRREZ D, MCGUIRE PK, BARKER GJ, ROIZ-SANTIAÑEZ R, MATA I, DE LUCAS EM, RODRÍGUEZ-SÁNCHEZ JM, AYESA-ARRIOLA R, VAZQUEZ-BARQUERO JL, CRESPO-FACORRO B. White Matter Integrity and Cognitive Impairment in First-Episode Psychosis. Am J Psychiatry. 2010 Apr; 167(4):451-8. IF: 12,522 / Q1

88. PEREZ-IGLESIAS R, MATA I, AMADO JA, BERJA A, GARCIA-UNZUETA MT, MARTÍNEZ GARCÍA O, ARRANZ MJ, VAZQUEZ-BARQUERO JL, CRESPO-FACORRO B. Effect of FTO, SH2B1, LEP, and LEPR polymorphisms on weight gain associated with antipsychotic treatment. J Clin Psychopharmacol. 2010 Dec;30(6):661-6. IF: 5,092 / Q1

89. RAPADO-CASTRO M, SOUTULLO C, FRAGUAS D, ARANGO C, PAYÁ B, CASTRO-FORNIELES J, GONZÁLEZ-PINTO A, PARELLADA M, GRAELL M, BAEZA I, BOMBIN I. Predominance of symptoms over time in early-onset psychosis: a principal component factor analysis of the positive and negative syndrome scale. J Clin Psychiatry. 2010 Mar;71(3):327-337. IF: 5,218 / Q1

90. RODRÍGUEZ-SÁNCHEZ JM, AYESA-ARRIOLA R, MATA I, MORENO-CALLE T, PEREZ-IGLESIAS R, GONZÁLEZ-BLANCH C, PERIAÑEZ JA, VAZQUEZ-BARQUERO JL, CRESPO-FACORRO B. Cannabis use and cognitive functioning in first-episode schizophrenia patients. Schizophr Res. 2010 Dec;124(1-3):142-51. IF: 4,458 / Q1

91. ROIZ-SANTIÁÑEZ R, PÉREZ-IGLESIAS R, QUINTERO C, TORDESILLAS-GUTIÉRREZ D, MATA I, AYESA R, SÁNCHEZ JM, GUTIÉRREZ A, SANCHEZ E, VÁZQUEZ-BARQUERO JL, CRESPO-FACORRO B. Insular cortex thinning in first episode schizophrenia patients. Psychiatry Res-Neuroim. 2010; 182(3): 216-22. IF: 2,064 / Q2

92. ROIZ-SANTIÁÑEZ R, PÉREZ-IGLESIAS R, QUINTERO C, TORDESILLAS-GUTIÉRREZ D, MATA I, GUTIÉRREZ A, SÁNCHEZ E, PAZOS A, TABARÉS-SEISDEDOS R, VÁZQUEZ-BARQUERO JL, CRESPO-FACORRO B. Temporal pole morphology in first-episode schizophrenia patients: Clinical correlations. Psychiatry Res-Neuroim. 2010 Dec;184(3):189-91. IF: 2,064 / Q2

93. ROJO E, PINO O, GUILERA G, GÓMEZ-BENITO J, PURDON SE, CRESPO-FACORRO B, CUESTA MJ, FRANCO M, MARTÍNEZ-ARÁN A, SEGARRA N, TABARÉS-SEISDEDOS R, VIETA E, BERNARDO M, MESA F, REJAS J; SPANISH WORKING GROUP IN COGNITIVE FUNCTION. Neurocognitive diagnosis and cut-off scores of the Screen for Cognitive Impairment in Psychiatry (SCIP-S). Schizophr Res. 2010; 116(2-3):243-51. IF: 4,458 / Q1

94. VAZQUEZ-BOURGON J, ARRANZ MJ, MATA I, PELAYO-TERAN JM, PEREZ-IGLESIAS R, MEDINA-GONZALEZ L, CARRASCO-MARIN E, VAZQUEZ-BARQUERO JL, CRESPO-FACORRO B. Serotonin transporter polymorphisms and early response to antipsychotic treatment in first-episode of psychosis. Psychiatr Res. 2010; 175(3):189-194. IF: 2,373 / Q2

Page 13: PUBLICACIONES EN REVISTAS NACIONALES E INTERNACIONALES · g, tabares-seisdedos r, ayuso-mateos jl, vÁzquez-barquero jl, crespo- FACORRO B. Predictors of neurocognitive impairment

UN

IDAD

DE

INVE

STIG

ACIÓ

N E

N P

SIQ

UIA

TRÍA

DE

CAN

TABR

IA |

Hos

pita

l Uni

vers

itario

"M

arqu

és d

e Va

ldec

illa"

| Se

rvic

io d

e Ps

iqui

atría

Resi

denc

ia C

anta

bria

, pla

nta

12.ª

Este

| Av

da. C

arde

nal H

erre

ra O

ria, s

/n.

| 390

11 S

ANTA

ND

ER, C

anta

bria

, Spa

in

Tel.:

(+34

) 942

-202

545

| Fax

: (+3

4) 9

42-2

0344

7 | e

-mai

l: ui

pcs1

1@hu

mv.

es

PUBLICACIONES EN REVISTAS NACIONALES E INTERNACIONALES

Página 13 de 15

95. VÁZQUEZ RIVERA S, GÓMEZ MAGARIÑOS S, GONZÁLEZ-BLANCH C. [Effects on the brain of effective psychological treatments for anxiety disorders: a systematic review]. Actas Esp Psiquiatr. 2010 Jul; 38(4):239-48. Spanish. IF: 0,695 / Q4

96. ZABALA A, RAPADO M, ARANGO C, ROBLES O, DE LA SERNA E, GONZÁLEZ C, RODRÍGUEZ SÁNCHEZ JM, ANDRÉS P, MAYORAL M, BOMBÍN I. Neuropsychological functioning in early-onset first-episode psychosis: comparison of diagnostic subgroups. Eur Arch Psy Clin N. 2010 Apr; 260(3):225-33. IF: 2,747 / Q2

97. ALVAREZ-JIMÉNEZ M, GLEESON JF, COTTON S, WADE D, GEE D, PEARCE T, CRISP K, SPILIOTACOPOULOS D, NEWMAN B, MCGORRY PD. Predictors of adherence to cognitive-behavioural therapy in first-episode psychosis. Can J Psychiatry. 2009; 54(10):710-8. IF: 2,293 / Q2

98. ALVAREZ-JIMENEZ M, HETRICK SE, GONZALEZ-BLANCH C, GLEESON JF, MCGORRY PD. In research, aces don´t win the match! Br J Psychiatry. 2009;194(1):89. IF: 5,777 / Q1

99. BAEZA I, GRAELL M, MORENO D, CASTRO-FORNIELES J, PARELLADA M, GONZÁLEZ-PINTO A, PAYÁ B, SOUTULLO C, DE LA SERNA E, ARANGO C. Cannabis use in children and adolescents with first episode psychosis: influence on psychopathology and short-term outcome (CAFEPS study). Schizophr Res. 2009; 113(2-3):129-37. IF: 4,458 / Q1

100. BALANZÁ-MARTÍNEZ V, CUESTA MJ, ARANGO C, CRESPO-FACORRO B, TABARÉS-SEISDEDOS R. Longitudinal course of cognition in schizophrenia. Br J Psychiatry. 2009; 195(1):84. IF: 5,777 / Q1

101. CRESPO-FACORRO B, PEREZ-IGLESIAS R, MATA I, RODRIGUEZ-SANCHEZ JM, PELAYO-TERAN JM, TORDESILLAS-GUTIERREZ D, ROIZ-SANTIAÑEZ R, GAITE L, HERRERA CASTANEDO S, MARTINEZ-GARCIA O, PARDO-GARCIA G, AYESA R, RAMIREZ-BONILLA ML, VAZQUEZ-BARQUERO JL. Recent Findings On Clinical And Biological Bases From The Longitudinal Intervention Program Of First-Episode Non-Affective Psychosis (PAFIP) Of Cantabria. Eur. J. Psychiat. 2009; 23(Supl.):167-173. IF: 0,462 / Q4

102. CRESPO-FACORRO B, RODRÍGUEZ-SÁNCHEZ JM, PÉREZ-IGLESIAS R, MATA I, AYESA R, RAMIREZ-BONILLA M, MARTÍNEZ-GARCIA O, VÁZQUEZ-BARQUERO JL. Neurocognitive effectiveness of haloperidol, risperidone, and olanzapine in first-episode psychosis: a randomized, controlled 1-year follow-up comparison. J Clin Psychiatry. 2009; 70(5):717-29. IF: 5,218 / Q1

103. CRESPO-FACORRO B, ROIZ-SANTIÁÑEZ R, PÉREZ-IGLESIAS R, TORDESILLAS-GUTIÉRREZ D, MATA I, RODRÍGUEZ-SÁNCHEZ JM, DE LUCAS EM, VÁZQUEZ-BARQUERO JL. Specific brain structural abnormalities in first-episode schizophrenia. A comparative study with patients with schizophreniform

Page 14: PUBLICACIONES EN REVISTAS NACIONALES E INTERNACIONALES · g, tabares-seisdedos r, ayuso-mateos jl, vÁzquez-barquero jl, crespo- FACORRO B. Predictors of neurocognitive impairment

UN

IDAD

DE

INVE

STIG

ACIÓ

N E

N P

SIQ

UIA

TRÍA

DE

CAN

TABR

IA |

Hos

pita

l Uni

vers

itario

"M

arqu

és d

e Va

ldec

illa"

| Se

rvic

io d

e Ps

iqui

atría

Resi

denc

ia C

anta

bria

, pla

nta

12.ª

Este

| Av

da. C

arde

nal H

erre

ra O

ria, s

/n.

| 390

11 S

ANTA

ND

ER, C

anta

bria

, Spa

in

Tel.:

(+34

) 942

-202

545

| Fax

: (+3

4) 9

42-2

0344

7 | e

-mai

l: ui

pcs1

1@hu

mv.

es

PUBLICACIONES EN REVISTAS NACIONALES E INTERNACIONALES

Página 14 de 15

disorder, non-schizophrenic non-affective psychoses and healthy volunteers. Schizophr Res. 2009; 115:191–201. IF: 4,458 / Q1

104. CRESPO-FACORRO B, PEREZ-IGLESIAS R, MATA I. Adjunctive transdermal oestradiol improves positive symptoms and general psychopathology in women with schizophrenia. Evid Based Ment Health. 2009;12(2):55. IF: ? / Q?

105. GARCÍA-GÓMEZ MC, ORDOÑEZ GONZÁLEZ J, GÓMEZ DEL BARRIO A, ARRECHEA GARCÍA N. Rhabdomyolysis and drug abuse in a patient with bulimia nervosa. Int J Eat Disord. 2009; 42(1):93-5. IF: 2,797 / Q2

106. GIL SANZ D, DIEGO LORENZO M, BENGOCHEA SECO R, ARRIETA RODRÍGUEZ M, LASTRA MARTÍNEZ I, SÁNCHEZ CALLEJA R, ALVAREZ SOLTERO A. Efficacy of a social cognition training program for schizophrenic patients: a pilot study. Span J Psychol. 2009 May;12(1):184-91. IF: 0,835 / Q3

107. GLEESON JF, COTTON SM, ALVAREZ-JIMENEZ M, WADE D, GEE D, CRISP K, PEARCE T, NEWMAN B, SPILIOTACOPOULOS D, CASTLE D, MCGORRY PD. A randomized controlled trial of relapse prevention therapy for first-episode psychosis patients. J Clin Psychiatry. 2009; 70(4):477-86. IF: 5,218 / Q1

108. GUILERA G, PINO O, GOMEZ-BENITO J, ROJO JE, VIETA E, TABARES-SEISDEDOS R, SEGARRA N, MARTINEZ-ARAN A, FRANCO M, CUESTA MJ, CRESPO-FACORRO B, BERNARDO M, PURDON SE, DIEZ T, REJAS J; SPANISH WORKING GROUP IN COGNITIVE FUNCTION. Clinical usefulness of the screen for cognitive impairment in psychiatry (SCIP-S) scale in patients with type I bipolar disorder. Health Qual Life Out. 2009; 7:28. IF: 2,456 / Q1

109. KYRIAKOPOULOS M, PEREZ-IGLESIAS R, WOOLLEY JB, KANAAN RA, VYAS NS, BARKER GJ, FRANGOU S, MCGUIRE PK. Effect of age at onset of schizophrenia on white matter abnormalities. Br J Psychiatry. 2009; 195(4):346-53. IF: 5,777 / Q1

110. MATA I, PEREZ-IGLESIAS R, ROIZ-SANTIAÑEZ R, TORDESILLAS-GUTIERREZ D, GONZALEZ-MANDLY A, VAZQUEZ-BARQUERO JL, CRESPO-FACORRO B. A neuregulin 1 variant is associated with increased lateral ventricle volume in patients with first-episode schizophrenia. Biol Psychiatry. 2009; 65(6):535-40. IF: 8,926 / Q1

111. MORENO D, MORENO-IÑIGUEZ M, VIGIL D, CASTRO-FORNIELES J, ORTUÑO F, GONZÁLEZ-PINTO A, PARELLADA M, BAEZA I, OTERO S, GRAELL M, ALDAMA A, ARANGO C. Obstetric complications as a risk factor for first psychotic episodes in childhood and adolescence. Eur Child Adolesc Psychiatry. 2009; 18(3):180-4. IF: 1,651 / Q3

112. NUEVO R, DUNN G, DOWRICK C, VÁZQUEZ-BARQUERO JL, CASEY P, DALGARD OS, LEHTINEN V, AYUSO-MATEOS JL. Cross-cultural equivalence of the Beck Depression Inventory: a five-country analysis from the ODIN study. J Affect Disord. 2009; 114(1-3):156-62. IF: 3,763 / Q1

Page 15: PUBLICACIONES EN REVISTAS NACIONALES E INTERNACIONALES · g, tabares-seisdedos r, ayuso-mateos jl, vÁzquez-barquero jl, crespo- FACORRO B. Predictors of neurocognitive impairment

UN

IDAD

DE

INVE

STIG

ACIÓ

N E

N P

SIQ

UIA

TRÍA

DE

CAN

TABR

IA |

Hos

pita

l Uni

vers

itario

"M

arqu

és d

e Va

ldec

illa"

| Se

rvic

io d

e Ps

iqui

atría

Resi

denc

ia C

anta

bria

, pla

nta

12.ª

Este

| Av

da. C

arde

nal H

erre

ra O

ria, s

/n.

| 390

11 S

ANTA

ND

ER, C

anta

bria

, Spa

in

Tel.:

(+34

) 942

-202

545

| Fax

: (+3

4) 9

42-2

0344

7 | e

-mai

l: ui

pcs1

1@hu

mv.

es

PUBLICACIONES EN REVISTAS NACIONALES E INTERNACIONALES

Página 15 de 15

113. OTERO S. Psychopathology and psychological adjustment in children and adolescents with epilepsy. World J Pediatr. 2009; 5(1):12-7. IF: 0,365 / Q4

114. OTERO-CUESTA S, FERNÁNDEZ-TORRE O, GONZÁLEZ-LAMUÑO D. [PANDAS with a chorea-like clinical presentation and associated autoimmune pathology: a case report]. Rev Neurología. 2009; 49(2):76-8. IF: 1,234 / Q3

115. PARELLADA M, FRAGUAS D, BOMBÍN I, OTERO S, CASTRO-FORNIELES J, BAEZA I, GONZALEZ-PINTO A, GRAELL M, SOUTULLO C, PAYA B, ARANGO C. Insight correlates in child- and adolescent-onset first episodes of psychosis: results from the CAFEPS study. Psychol Med. 2009; 39(9):1433-45. IF: 5,012 / Q1

116. PEREZ-IGLESIAS R, MATA I, PELAYO-TERAN JM, AMADO JA, GARCIA-UNZUETA MT, BERJA A, MARTINEZ-GARCIA O, VAZQUEZ-BARQUERO JL, CRESPO-FACORRO B. Glucose and lipid disturbances after 1 year of antipsychotic treatment in a drug-naïve population. Schizophr Res. 2009; 107(2-3):115-21. IF: 4,458 / Q1

117. REIG S, SÁNCHEZ-GONZÁLEZ J, ARANGO C, CASTRO J, GONZÁLEZ-PINTO A, ORTUÑO F, CRESPO-FACORRO B, BARGALLÓ N, DESCO M. Assessment of the increase in variability when combining volumetric data from different scanners. Hum Brain Mapp. 2009; 30(2):355-68. IF: 6,256 / Q1

118. ROBINSON JL, BEARDEN CE, MONKUL ES, TORDESILLAS-GUTIERREZ D, VELLIGAN DI, FRANGOU S, GLAHN DC. Fronto-temporal dysregulation in remitted bipolar patients: an fMRI delayed-non-match-to-sample (DNMS) study. Bipolar Disord. 2009; 11:351–360. IF: 5,502 / Q1

119. SÁNCHEZ-CUBILLO I, PERIÁÑEZ JA, ADROVER-ROIG D, RODRÍGUEZ-SÁNCHEZ JM, RÍOS-LAGO M, TIRAPU J, BARCELÓ F. Construct validity of the Trail Making Test: role of task-switching, working memory, inhibition/interference control, and visuomotor abilities. J Int Neuropsychol Soc. 2009 may;15(3):438-50. IF: 2,766 / Q2

120. VAN WIJNGAARDEN B, KOETER M, KNAPP M, TANSELLA M, THORNICROFT G, VÁZQUEZ-BARQUERO JL, SCHENE A. Caring for people with depression or with schizophrenia: are the consequences different? Psychiatry Res. 2009 Aug 30;169(1):62-9. IF: 2,373 / Q2

121. VÁZQUEZ-BARQUERO JL. The incorporation of the disability construct as an independent axis in the DSM-V and ICD-11 diagnostic systems. World Psychiatry. 2009;8(2):92-4. IF: 4,375 / Q1

122. VÁZQUEZ-RIVERA S, GONZÁLEZ-BLANCH C, RODRÍGUEZ-MOYA L, MORÓN D, GONZÁLEZ-VIVES S, CARRASCO JL. Brief cognitive-behavioral therapy with fibromyalgia patients in routine care. Compr Psychiatry. 2009 Nov-Dec; 50(6):517-25. IF: 2,082 / Q3